 Curtis Henry
Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 4 | 2022 | 279 | 1.030 |
Why?
| | Leukemia | 5 | 2024 | 230 | 0.970 |
Why?
| | Burkitt Lymphoma | 2 | 2023 | 56 | 0.940 |
Why?
| | Aging | 4 | 2021 | 1774 | 0.930 |
Why?
| | Hematopoiesis | 2 | 2017 | 184 | 0.850 |
Why?
| | Interleukin-12 | 4 | 2022 | 118 | 0.830 |
Why?
| | Galectins | 1 | 2022 | 22 | 0.760 |
Why?
| | Dendritic Cells | 4 | 2024 | 481 | 0.720 |
Why?
| | Cell- and Tissue-Based Therapy | 1 | 2021 | 77 | 0.670 |
Why?
| | Precursor Cells, B-Lymphoid | 2 | 2017 | 39 | 0.620 |
Why?
| | Fusion Proteins, bcr-abl | 2 | 2015 | 69 | 0.570 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 48 | 0.550 |
Why?
| | Interleukin-1 | 1 | 2021 | 956 | 0.530 |
Why?
| | Folic Acid | 1 | 2017 | 182 | 0.510 |
Why?
| | Cell Transformation, Neoplastic | 2 | 2015 | 319 | 0.490 |
Why?
| | CD8-Positive T-Lymphocytes | 6 | 2024 | 855 | 0.490 |
Why?
| | Cytokines | 5 | 2023 | 2022 | 0.460 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2015 | 129 | 0.450 |
Why?
| | Genetic Fitness | 2 | 2011 | 56 | 0.420 |
Why?
| | Tumor Microenvironment | 5 | 2024 | 627 | 0.420 |
Why?
| | Dietary Supplements | 1 | 2017 | 532 | 0.410 |
Why?
| | Interleukin-23 | 2 | 2010 | 19 | 0.410 |
Why?
| | Adenoma | 1 | 2015 | 213 | 0.400 |
Why?
| | Mice, Transgenic | 6 | 2021 | 2135 | 0.390 |
Why?
| | c-Mer Tyrosine Kinase | 2 | 2024 | 44 | 0.380 |
Why?
| | Inflammation Mediators | 1 | 2015 | 505 | 0.380 |
Why?
| | Listeria monocytogenes | 2 | 2010 | 123 | 0.380 |
Why?
| | Mice | 15 | 2024 | 16983 | 0.370 |
Why?
| | Lymphopoiesis | 1 | 2010 | 26 | 0.350 |
Why?
| | Hematopoietic Stem Cells | 2 | 2010 | 382 | 0.340 |
Why?
| | Precursor B-Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2023 | 76 | 0.340 |
Why?
| | Mice, Inbred BALB C | 4 | 2021 | 1248 | 0.330 |
Why?
| | Listeriosis | 1 | 2010 | 67 | 0.320 |
Why?
| | Interleukin-12 Subunit p35 | 1 | 2008 | 3 | 0.310 |
Why?
| | Chemokine CCL1 | 1 | 2008 | 2 | 0.310 |
Why?
| | Chemokine CCL17 | 1 | 2008 | 5 | 0.310 |
Why?
| | Interleukin-12 Subunit p40 | 1 | 2008 | 9 | 0.310 |
Why?
| | Obesity | 1 | 2022 | 2885 | 0.300 |
Why?
| | Biomarkers, Tumor | 1 | 2015 | 1161 | 0.290 |
Why?
| | Animals | 16 | 2024 | 35409 | 0.280 |
Why?
| | Colorectal Neoplasms | 1 | 2015 | 748 | 0.280 |
Why?
| | Adjuvants, Immunologic | 1 | 2008 | 222 | 0.280 |
Why?
| | Lymphocyte Activation | 2 | 2019 | 1110 | 0.260 |
Why?
| | Stem Cells | 1 | 2010 | 578 | 0.260 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5468 | 0.240 |
Why?
| | Mice, Knockout | 3 | 2024 | 2888 | 0.240 |
Why?
| | Receptor Protein-Tyrosine Kinases | 1 | 2024 | 231 | 0.200 |
Why?
| | Proto-Oncogene Proteins c-ets | 1 | 2022 | 53 | 0.190 |
Why?
| | Germ-Line Mutation | 1 | 2022 | 140 | 0.180 |
Why?
| | Hematologic Neoplasms | 1 | 2023 | 141 | 0.180 |
Why?
| | Antibodies, Bispecific | 1 | 2020 | 49 | 0.160 |
Why?
| | Cell Line, Tumor | 3 | 2022 | 3185 | 0.160 |
Why?
| | Bone Marrow | 2 | 2022 | 272 | 0.150 |
Why?
| | Calcineurin | 1 | 2019 | 103 | 0.150 |
Why?
| | Inflammation | 3 | 2022 | 2748 | 0.150 |
Why?
| | Metabolism | 1 | 2017 | 38 | 0.140 |
Why?
| | Nitriles | 1 | 2018 | 169 | 0.130 |
Why?
| | Nucleotides | 1 | 2017 | 122 | 0.130 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 149 | 0.130 |
Why?
| | Programmed Cell Death 1 Receptor | 1 | 2018 | 232 | 0.130 |
Why?
| | Inflammasomes | 1 | 2018 | 126 | 0.130 |
Why?
| | Stem Cell Niche | 1 | 2015 | 53 | 0.120 |
Why?
| | Cell Line | 1 | 2021 | 2780 | 0.120 |
Why?
| | Cells, Cultured | 3 | 2018 | 4102 | 0.110 |
Why?
| | Anti-Inflammatory Agents | 1 | 2018 | 482 | 0.110 |
Why?
| | Humans | 13 | 2024 | 129847 | 0.110 |
Why?
| | Macrophages | 2 | 2018 | 1489 | 0.110 |
Why?
| | Mutation | 3 | 2022 | 3706 | 0.100 |
Why?
| | Apoptosis | 1 | 2022 | 2489 | 0.100 |
Why?
| | Protein Kinase Inhibitors | 1 | 2018 | 886 | 0.100 |
Why?
| | T-Lymphocytes | 1 | 2020 | 1937 | 0.100 |
Why?
| | Interleukin-7 | 1 | 2010 | 59 | 0.090 |
Why?
| | Immunotherapy, Active | 1 | 2010 | 9 | 0.090 |
Why?
| | Immunologic Factors | 2 | 2023 | 229 | 0.080 |
Why?
| | Bone Marrow Transplantation | 1 | 2010 | 277 | 0.080 |
Why?
| | Antineoplastic Agents | 1 | 2020 | 2045 | 0.080 |
Why?
| | Oncogenes | 1 | 2009 | 110 | 0.080 |
Why?
| | Neoplasms | 1 | 2023 | 2454 | 0.070 |
Why?
| | Immunity, Cellular | 1 | 2010 | 265 | 0.070 |
Why?
| | Immunologic Memory | 1 | 2010 | 349 | 0.070 |
Why?
| | Case-Control Studies | 1 | 2015 | 3384 | 0.070 |
Why?
| | Evolution, Molecular | 1 | 2011 | 462 | 0.070 |
Why?
| | Cell Communication | 1 | 2008 | 301 | 0.070 |
Why?
| | Female | 5 | 2021 | 68829 | 0.070 |
Why?
| | Up-Regulation | 1 | 2008 | 836 | 0.060 |
Why?
| | Interferon-gamma | 1 | 2008 | 773 | 0.060 |
Why?
| | Immunity, Innate | 1 | 2011 | 804 | 0.060 |
Why?
| | Immunotherapy | 2 | 2020 | 596 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5444 | 0.060 |
Why?
| | Male | 4 | 2021 | 63759 | 0.050 |
Why?
| | Sialic Acid Binding Immunoglobulin-like Lectins | 1 | 2023 | 9 | 0.050 |
Why?
| | Prospective Studies | 1 | 2015 | 7158 | 0.050 |
Why?
| | Immunoglobulins | 1 | 2023 | 162 | 0.050 |
Why?
| | Thrombopoiesis | 1 | 2022 | 8 | 0.050 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2019 | 1058 | 0.050 |
Why?
| | Adaptive Immunity | 1 | 2023 | 161 | 0.050 |
Why?
| | Germ Cells | 1 | 2022 | 60 | 0.050 |
Why?
| | CD3 Complex | 1 | 2020 | 102 | 0.040 |
Why?
| | Antigens, CD19 | 1 | 2020 | 120 | 0.040 |
Why?
| | Tumor Escape | 1 | 2019 | 39 | 0.040 |
Why?
| | Repressor Proteins | 1 | 2022 | 404 | 0.040 |
Why?
| | Polymers | 1 | 2023 | 479 | 0.040 |
Why?
| | Gene Knockdown Techniques | 1 | 2019 | 317 | 0.040 |
Why?
| | Polyethylene Glycols | 1 | 2023 | 612 | 0.040 |
Why?
| | Forkhead Transcription Factors | 1 | 2018 | 184 | 0.040 |
Why?
| | Caspase 1 | 1 | 2018 | 142 | 0.030 |
Why?
| | Signal Transduction | 1 | 2010 | 4935 | 0.030 |
Why?
| | Gene Deletion | 1 | 2018 | 380 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2023 | 1119 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 237 | 0.030 |
Why?
| | RNA | 1 | 2022 | 877 | 0.030 |
Why?
| | Aged | 1 | 2015 | 22107 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 369 | 0.030 |
Why?
| | Monocytes | 1 | 2018 | 554 | 0.030 |
Why?
| | B-Lymphocytes | 1 | 2020 | 816 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2018 | 872 | 0.030 |
Why?
| | Middle Aged | 1 | 2015 | 31177 | 0.030 |
Why?
| | Disease Progression | 1 | 2019 | 2628 | 0.020 |
Why?
| | DNA Damage | 1 | 2009 | 383 | 0.020 |
Why?
| | Reactive Oxygen Species | 1 | 2009 | 592 | 0.020 |
Why?
| | Child | 1 | 2023 | 20962 | 0.010 |
Why?
|
|
Henry's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|